Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Synairgen (SYNG)

London
Currency in GBP
Disclaimer
6.40
-0.62(-8.83%)
Closed

SYNG Comments

looks like SNG are writing the P3 protocol... waiting for an RNS to confirm
finally its starting waiting for confirmation!!!
wish I was just buying in at these prices!
Trial results are very good, market makers have got this wrong!! Dont know what more i can say!
Nuts fall today...I'm out.
https://www.globenewswire.com/news-release/2021/04/30/2220373/0/en/Synairgen-announces-data-from-Home-Cohort-of-SG016-Phase-II-trial-of-inhaled-interferon-beta-in-COVID-19-patients-and-encouraging-combined-data-for-whole-SG016-trial.html
Anyone have any news on this?
looks like some good news may be coming...
Graham, a lot of SYNG's work is in trial phases and there tends to be not much movement then an increase when a trial is underway. I hope that we will see more significant moves upwards once trials prove successful. It looks like its going in the right direction so I'm holding for now.
Thanks for response, i knew pretty much what you've said there phase 3 seems very interesting with aniti viral inhaler, im holding long term.
Anyone's thoughts on this seen it mentioned repeatedly yet not taken off, also huge development into antiviral drugs!
Lansdowne is a distressed seller that has been selling down aggressively since the 24th Aug, but if you can see past the short term drag on the share price, this company is only going one way: up up and to a partnership with a big pharma. Target of £1-4bn mcap
They're going to be adopted by UK health system and many others for a patent that has been showed in peer reviewed research to deflect the need of reanimation therapies in COVID affected patients... great buy...
buy?
What happen to this stock ?
will this continue tomorrow??
AstraZeneca pozitiv news!
bet woodford is feeling ill and / or justified. He was a big shareholder.
game changer
240 WOW
Has the drug been confirmed about its effectiveness?
Wow....
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.